Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolio

Allegheny Technologies Issues $350M Senior Unsecured Notes

Published 11/28/2019, 05:25 AM
Updated 07/09/2023, 06:31 AM
ATI
-
AEM
-
GMOLQ
-
FNV
-

Allegheny Technologies Inc. (NYSE:ATI) issued $350 million of 5.875% senior unsecured notes due December 2027.

The company plans to use net proceeds from the issuance along with cash on hand to fund the redemption of all its outstanding $500 million of 5.95% senior notes due January 2021 on Dec 23, 2019. These actions are anticipated to reduce its debt by $150 million and lower annual interest expenses by $9 million, starting from 2020.

The company’s debt-reduction moves along with continuous efforts to lower risk within its defined benefit pension plan provide it increased financial flexibility to drive growth.

Allegheny Technologies expects to recognize debt extinguishment charges (linked to the redemption of 2021 notes) of $21 million in fourth-quarter 2019. Moreover, the release of part of deferred tax valuation allowances is anticipated to be $30-$40 million in the fourth quarter of 2019, roughly $5 million higher than the previously disclosed range.

The company’s income tax rate (on a reported basis) is anticipated to be 23-25% of 2020 pretax results. Cash tax requirements for 2020 are expected to be similar to that of 2019. Cash tax requirements are expected to be substantially lower than 2020 reported income tax rate due to the continuous benefits of net operating loss carryforwards in the United States.

Shares of Allegheny Technologies have lost 10.7% in the past year against the industry’s 2.8% growth.

The company ended the third quarter with cash and cash equivalents of $511.3 million, up more than 233% year over year. Its long-term debt rose to $1,541.7 million from $1,535.3 million in the year-ago quarter.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The company expects backlogs for single-aisle platforms to remain strong in the High Performance Materials & Components (“HPMC”) unit. However, it expects uneven order patterns along with inventory management actions by customers to negatively impact shipments in the fourth quarter of 2019. This is likely to partly offset the benefits from Allegheny Technologies’ larger share of high-value commercial jet engine material and components.

For the Flat-Rolled Products (“FRP”) unit, the company expects consistent profitability for the fourth quarter on sustained strength in high-value products in the United States as well as the STAL joint venture. Also, favorable impacts of higher nickel prices on raw material surcharge values are expected to drive the segment.

Allegheny Technologies Incorporated Price and Consensus

Zacks Rank & Stocks to Consider

Allegheny Technologies currently carries a Zacks Rank #4 (Sell).

Some better-ranked stocks in the basic materials space are General Moly, Inc (NYSE:GMO) , Franco-Nevada Corporation (TSX:FNV) and Agnico Eagle Mines Limited (NYSE:AEM) , each currently carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

General Moly has an expected earnings growth rate of 12.5% for the current fiscal year. The company’s shares have gained 53% in the past year.

Franco-Nevada has a projected earnings growth rate of 46.2% for 2019. The company’s shares have rallied 43.1% in a year.

Agnico Eagle has an estimated earnings growth rate of 168.6% for the current year. Its shares have moved up 66.5% in the past year.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>



Franco-Nevada Corporation (FNV): Free Stock Analysis Report

Agnico Eagle Mines Limited (AEM): Free Stock Analysis Report

General Moly, Inc (GMO): Free Stock Analysis Report

Allegheny Technologies Incorporated (ATI): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.